“What's new”
- 作者Stoughton, Richard B.
- 卷第1卷
- 期第1期
- 文件大小536.06KB
- 发表时间1979
- DOI10.1016/S0190-9622(79)80055-9
- 页码70-74
Aminoglycoside drugs in clinical practice: an evidence-based approach--authors' responseLeibovici, L.; Vidal, L.; Paul, M. · Journal of Antimicrobial Chemotherapy · 2009
Comment on: Aminoglycoside drugs in clinical practice: an evidence-based approachKeuleyan, E. E.; Kirilov, K. G. · Journal of Antimicrobial Chemotherapy · 2009
Aminoglycoside drugs in clinical practice: an evidence-based approach--authors' responseLeibovici, L.; Vidal, L.; Paul, M. · Journal of Antimicrobial Chemotherapy · 2009
Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trialsVidal, L.; Gafter-Gvili, A.; Borok, S.; Fraser, A.; Leibovici, L.; Paul, M. · Journal of Antimicrobial Chemotherapy · 2007
Meropenem: a microbiological overviewEdwards, J. R. · Journal of Antimicrobial Chemotherapy · 1995
The carbapenem familyBASKER, M. J. · Journal of Antimicrobial Chemotherapy · 1982
Significance of antibiotics in the environmentKummerer, K. · Journal of Antimicrobial Chemotherapy · 2003
Opportunistic and pathogenic fungiRichardson, M. D. · Journal of Antimicrobial Chemotherapy · 1991
Issues in antifungal susceptibility testingJohnson, E. M. · Journal of Antimicrobial Chemotherapy · 2008
Pharmacokinetics in childrenRoutledge, P. A. · Journal of Antimicrobial Chemotherapy · 1994
Quinolone resistance and Campylobacter spp.Piddock, Laura J. V. · Journal of Antimicrobial Chemotherapy · 1995
The quinine connectionGreenwood, David · Journal of Antimicrobial Chemotherapy · 1992